According to the American College of Rheumatology the diagnosis of fibromya
lgia is based on criteria for the classification of fibromyalgia consisting
entirely of clinical signs and symptoms. For diagnostic reasons autonomic
disturbances and mental features have to be considered. The distinction bet
ween fibromyalgia (tender points) and myofascial pain syndrome (trigger poi
nts) is essential. Internal and neurological disorders as a primary cause o
f fibromyalgia have to be excluded. The etiology and pathogenesis of fibrom
yalgia still remain uncertain. The myopathological patterns in fibromyalgia
are non-specific: type II fiber atrophy, an increase of lipid droplets, a
slight proliferation of mitochondria, and a slightly elevated incidence of
ragged red fibers. Initial reports on some allelic abnormalities in the ser
otonin system seem to highlight the important role of serotonin already pre
sumed earlier. Significantly high levels of substance P in the cerebrospina
l fluid of FM patients additionally support the impact of these neurotransm
itters on both nociceptive and antinociceptive mechanisms.